CTMH: CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection

Sponsor
Yangzhou University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05433467
Collaborator
(none)
5
1
1
12
0.4

Study Details

Study Description

Brief Summary

In this project, the preoperative anatomical location of micro hepatocellular carcinoma under the guidance of CT can provide guidance for accurate surgical resection. It may also shorten the operation time and reduce intraoperative bleeding.

Condition or Disease Intervention/Treatment Phase
  • Procedure: CT-guided localization for micro hepatocellular carcinoma before surgical resection
N/A

Detailed Description

General and basic information of the patients included in the study was collected. After preoperative preparation was completed, on the day of surgery, disposable pulmonary nodular localization needle (Ningbo Sonjiecang Biological Technology Co., LTD., Model: SS510-10) was used for the localization of micro hepatocellular carcinoma that could be found by preoperative CT enhancement or MRI. After the micro hepatocellular carcinoma was located under the guidance of CT, and then the patient was sent to the operating room. During the operation, the lesion was removed according to the tail line of the positioning needle and the position of the positioning needle.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
5 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Feasibility of CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
Actual Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: CT-guided localization for micro hepatocellular carcinoma before surgical resection

fter preoperative preparation was completed, on the day of surgery, disposable pulmonary nodular localization needle (Ningbo Sonjiecang Biological Technology Co., LTD., Model: SS510-10) was used for the localization of micro hepatocellular carcinoma that could be found by preoperative CT enhancement or MRI. After the micro hepatocellular carcinoma was located under the guidance of CT, and then the patient was sent to the operating room. During the operation, the lesion was removed according to the tail line of the positioning needle and the position of the positioning needle.

Procedure: CT-guided localization for micro hepatocellular carcinoma before surgical resection
After preoperative preparation was completed, on the day of surgery, disposable pulmonary nodular localization needle (Ningbo Sonjiecang Biological Technology Co., LTD., Model: SS510-10) was used for the localization of micro hepatocellular carcinoma that could be found by preoperative CT enhancement or MRI. After the micro hepatocellular carcinoma was located under the guidance of CT, and then the patient was sent to the operating room. During the operation, the lesion was removed according to the tail line of the positioning needle and the position of the positioning needle.

Outcome Measures

Primary Outcome Measures

  1. The position of the needle [During operation]

    The distance (mm) of the needle to the edge of hepatocellular carcinoma

Secondary Outcome Measures

  1. Operation time [During operation]

    The length of operation time (min)

  2. Intraoperative bleeding [During operation]

    The volume of intraoperative bleeding (ml)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Be at least 18 years old and give informed consent to participate in the study

  2. A preoperative (clinical, radiological, or histological) diagnosis of cirrhosis of the liver due to any cause.

  3. micro hepatocellular carcinoma (diameter less than 1cm).

  4. Preoperative CT plain scan could not find the lesion, and preoperative B-ultrasound could not find the lesion.

  5. Preoperative CT enhancement or MRI can detect the lesion.

Exclusion Criteria:
  1. Child-Pugh grade C

  2. Uncontrolled Hypertension

  3. Severe lung dysfunction

  4. Severe cardiac dysfunction

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Medical College, Yangzhou University Yangzhou Jiangsu China 225001

Sponsors and Collaborators

  • Yangzhou University

Investigators

  • Study Chair: Guo-Qing Jiang, MD, Clinical Medical College, Yangzhou University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guo-Qing Jiang, Clinical Professor, Yangzhou University
ClinicalTrials.gov Identifier:
NCT05433467
Other Study ID Numbers:
  • YZUC-012
First Posted:
Jun 27, 2022
Last Update Posted:
Jun 27, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guo-Qing Jiang, Clinical Professor, Yangzhou University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2022